Adjunctive Methylphenidate in the Treatment of Bulimia Nervosa Co-occurring with Bipolar Disorder and Substance Dependence

Innovations in Clinical Neuroscience

Anna I. Guerdjikova¹  Susan L. McElroy¹ 

[1] Dr. Guerdjikova is from the Lindner Center of HOPE in Mason, Ohio, and Dr. McElroy is from the Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine in Cincinnati, Ohio

关键词: methylphenidate;    stimulant;    bipolar disorder;    bulimia nervosa;   

DOI  :  

学科分类：精神健康和精神病学

来源: Matrix Medical Communications, LLC

【 摘 要 】

Bulimia nervosa is associated with bipolar disorder, substance dependence, attention-deficit hyperactivity disorder, and anxiety disorders. Few reports, however, have addressed the treatment of patients with all of these conditions. We describe a young woman with bulimia nervosa, bipolar I disorder, cocaine and alcohol dependence, attention-deficit hyperactivity disorder, and panic disorder who achieved a sustained (>1 year) remission of her bulimia nervosa symptoms and significant improvement of her attention-deficit hyperactivity disorder symptoms with adjunctive methylphenidate after her bipolar, substance use, and panic disorders were successfully treated with hospitalization, intensive psychotherapy, quetiapine, and lamotrigine. Further research into the use of stimulants in bulimia nervosa, including in patients with complex comorbidity, is required.

【 授权许可】

Unknown